Articles published by GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Today 17:15 EST
Via GlobeNewswire
Tickers
IOVA
RGNX Stockholder Alert: Robbins LLP Remind Investors of the Class Action Lawsuit Against REGENXBIO, Inc.
Today 17:11 EST
From Robbins LLP
Via GlobeNewswire
Tickers
RGNX
From Equinox Gold Corp.
Via GlobeNewswire
Tickers
TSX:EQX
From AirBoss of America
Via GlobeNewswire
Navient declares first quarter common stock dividend
Today 17:00 EST
From Navient Corporation
Via GlobeNewswire
Tickers
NAVI
Via GlobeNewswire
Tickers
RARE
From Zenas BioPharma
Via GlobeNewswire
Tickers
ZBIO
From TELA Bio, Inc.
Via GlobeNewswire
Tickers
TELA
MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND
Today 16:05 EST
Via GlobeNewswire
Tickers
MRTN
U.S. Global Investors Reports 12% Sequential Growth in Assets Under Management in Q2 of Fiscal 2026
Today 16:05 EST
Via GlobeNewswire
Tickers
GROW
Via GlobeNewswire
Tickers
ACAAU
From CAMP4 Therapeutics
Via GlobeNewswire
Tickers
CAMP
From Ottawa Bancorp, Inc.
Via GlobeNewswire
Tickers
OTTW
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
Today 16:01 EST
Via GlobeNewswire
Tickers
FOLD
From Surge Copper Corp.
Via GlobeNewswire
ENPH Investors Have Opportunity to Lead Enphase Energy, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Today 14:53 EST
From Schall Law
Via GlobeNewswire
Tickers
ENPH
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
Today 14:51 EST
From Schall Law
Via GlobeNewswire
Tickers
RGNX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
